Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

DRUG MARKETING

Pharmaceutical companies are bombarding the airwaves with TV ads, showering doctors with gifts to get them to prescribe more of their drugs, and practicing other marketing tactics that can get them into hot water. The topic of drug marketing will examine the myriad ways the industry pushes its products -- and the inevitable controversies that result.

Drug Marketing is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 443 news and 305 blog items. Read updated news, blogs, and resources about Drug Marketing. Find user-submitted articles and reactions on Drug Marketing from like-minded professionals.

Most Active

The most active stories in this topic based on user activity.

AIDS Group Blasts Glaxo Admore

The AIDS Healthcare foundation says Glaxo's latest print ads for an AIDS drug are tasteless.

Glaxo to Pare Ads on U.S. Televisionmore

Drug giant GlaxoSmithKline PLC is cutting back on its U.S. television advertising as it tries to spend its money more...

The Double-Edged Sword of Drug Marketing more

Jeffrey P. Kahn, Director, Center for Bioethics at the University of Minnesota, discusses whether prescription drugs...

Global Pharmaceuticals (Duke University Press, 2006) By By Adriana Pet...more

Interesting global perspectives on drug marketing. As summary says: "The ethnographies brought together in this...

New drug marketing code draws line at gift pensmore

Branded swag "has the look of an unprofessional relationship," said Billy Tauzin, president and CEO of of...

Massachusetts Passes Bill To Restrict Marketing more

State's House and Senate compromise with legislation that excludes a controversial ban on gifts to doctors.

Drug Ads Target Childrenmore

A Boston cable network that broadcasts in schools gets pinged for showing ads for two prescription acne medications.

FDA Can't Police Off-Label Marketingmore

A GAO report blasts the FDA for failing to police the improper off-label marketing of prescription drugs.

Pfizer Suit on Neurontin Is Dropped more

A family dropped its lawsuit after an anonymous donor paid them.

Sanofi Drug Found Promising for Heart Ailmentmore

Sanofi-Aventis got a big push Wednesday for a new drug for a potentially serious heart condition when a leading medical...

Patients and Innovationmore

The Royal College of Physicians weighs in on the lack of innovation in the pharma industry.

French Revolution - Pharmaceutical Executivemore

"I have probably got six months to ask tough questions and push the boundaries before I fall in love with the...

FTC Sues in 'Pay-for-Delay' Pactmore

The Federal Trade Commission has intervened in a deal in which a maker of a branded testosterone-replacement drug paid...

Reports: GlaxoSmithKline to cut thousands of jobsmore

British drug maker GlaxoSmithKline will cut thousands of jobs when it announces full-year results this week, two...

Pfizer buying Wyeth for $68 billion in cash and stockmore

Pfizer Inc., the world's top drug maker, said Monday it will buy rival Wyeth for $68 billion in the biggest...

Walgreens Dabbles in Drug Adsmore

Online videos pitch prescription drugs--and the drugstore's prescription savings plans.

Calling All Pharma Companies: Docs Love Social Media | Kyle Lacy, Soci...more

Physicians increasingly using social media

Do Transparency Laws Backfire?more

A state senator criticizes loopholes in laws meant to expose payments pharma companies make to doctors.

FDA Allows Off-Label Journal Promosmore

About a week before the climate in Washington, D.C., turns inside out, FDA officials have ushered in new rules that...

Senator Moves to Stop Scientific Ghostwritingmore

Senator Charles E. Grassley, an Iowa Republican who has led a long-running investigation of conflicts of interest in...

Arthritis drugs raise cancer risk in kidsmore

J&J and Amgen are among the companies that will have to revise product labels to reflect the risk.

Forest Laboratories’ Celexa Doesn’t Help Children With Autismmore

Celexa, part of a class of antidepressants widely prescribed for autistic children, didn’t help reduce their repetitive...

Merck Won’t Face Punitive Damages in Fosamax Trial more

Merck & Co., facing more than 850 lawsuits over claims that its osteoporosis drug Fosamax may cause irreversible...

FDA questions Lilly, Amgen cancer drug trialsmore

U.S. health regulators are questioning whether clinical trials proposed by ImClone Systems and Amgen Inc will be...

DTC In the Crosshairs of Congressman Waxmanmore

Eye on FDA examines intent of Rep. Waxman to place a moratorium oin direct to consumer advertising in next...

Topic Feed: Most active content in Drug Marketing

Top Sources: Drug Marketing

  • Reuters
  • New York Times
  • adage.com
  • Wall Street Journal Online
  • jpost.com
  • Forbes.com
  • News
  • online.wsj.com
  • MarketWatch
  • bloomberg.com

Most Active Users in this Topic

see all contributors in Drug Marketing

Featured White Papers

Post a Job

Jobs in this Topic

Process Sciences Associate Drug Product Regeneron | Rensselaer, NY
Posted: Jun 14
Marketing Director-Assisted Living Job HCR Manor Care | King of Prussia, PA
Posted: Jun 12
Lead Analyst Pharma Sales / Marketing Analytics Group Technology | Swiftwater, PA
Posted: Apr 27
Pharmacist (Investigational Drug Research Quality Program Manager) United States Department of Veterans Affairs | Martinez, CA
Posted: Jun 13

Report comment contains invalid characters. ()
cancel
Search Cancel